Skip to main content
. 2017 May 24;8(30):50305–50313. doi: 10.18632/oncotarget.18148

Figure 2. GBM biomarkers is immunopositive in patient specimen.

Figure 2

Representative IHC images are shown for vimentin A., nestin B., Olig-2 C. and the ki67 D. (which labeling index was 70 %)